Project Grant R01DK142896
- Federal Grant Award Summary Boston Medical Center Corporation received a $388,294 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 1, 2026, with completion by November 30, 2030. The grant funds the development and testing of a first-person storytelling (FPS) narrative video education intervention tailored for Spanish-speaking patients...
- Federal Grant Award Summary Beth Israel Deaconess Medical Center received a $1.32 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 4, 2025, with completion targeted for June 30, 2030. The award funds basic biomedical research to elucidate the genetic and molecular mechanisms of APOL1 (Apolipoprotein L1) nephropathy, a kidney disease...
- Federal Grant Award Summary Massachusetts General Hospital's Research Management Division received a $1,271,635 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 3, 2025, with completion targeted for May 31, 2029. The award funds research to elucidate the non-canonical role of FANCD2 (Fanconi Anemia Complementation Group D2 protein)...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $251,626 Project Grant award dated April 1, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds a five-year research initiative (completion date March 31, 2031) investigating c-kit receptor signaling in kidney collecting duct function. The research aims to elucidate the molecular...
- Federal Project Grant Award Summary Brigham & Women's Hospital Inc. received a $2.47 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2029. This award supports the development of a novel, kidney-draining lymph node (KLN)-targeted nanotherapeutic to treat crescentic glomerulonephritis (CGN), a...
- Federal Project Grant Award Summary Boston Children's Hospital received an $801,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with a completion date of July 31, 2030. This award supports research investigating the role of stress granules in red blood cell development and erythropoiesis, specifically examining...
- Federal Grant Award Summary New York University School of Medicine received a $1.72 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 10, 2025, with completion expected August 31, 2030. The research deliverables include a comprehensive analysis of long-term health outcomes for living kidney donors (LKDs) utilizing the COSMOS...
- Federal Project Grant Award Summary The University of California, San Francisco received a $810,330 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 4, 2025, through June 30, 2030. This research initiative addresses significant racial and ethnic disparities in access to preferred kidney replacement therapy (KRT) modalities,...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Boston University Medical Campus a $478,011 Project Grant (CFDA 93.847: Diabetes, Digestive, and Kidney Diseases Extramural Research) on September 11, 2025, with completion anticipated by August 31, 2027. This grant funds development of an automated deep learning platform specifically designed to analyze transmission electron microscopy (TEM) images of kidney tissue. The platform...
- Federal Project Grant Award Summary Boston University, through its Medical Campus in Roxbury, Massachusetts, received a $817,498 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective February 18, 2026, through January 31, 2031, funds research into vasculature and beige adipose tissue remodeling in obesity-related metabolic dysfunction. The...
Boston Medical Center Corporation received a $918,576 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded June 24, 2026, with completion targeted for February 28, 2031. The grant funds research investigating the mechanistic link between sociodemographic stressors and the incidence of chronic kidney disease (CKD) and end-stage kidney disease (ESKD) in Black women, who experience approximately four times the risk of ESKD compared to white women. The research employs the Black Women's Health Study cohort to model how cumulative allostatic load—chronic stress measured through nine objective biomarkers—accelerates renal decline. The project delivers epidemiologic analysis and mediation studies examining associations between neighborhood-level socioeconomic disadvantage (measured via Area Deprivation Index and Income Concentration at Extremes) and kidney disease incidence, while identifying health-related behavioral and clinical pathways connecting social factors to CKD development. Findings are intended to advance risk identification and modeling strategies, enabling more targeted interventions to address disparities in kidney disease among Black women.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $918.6k | 7/7/26 |